COMMUNIQUÉS West-GlobeNewswire

Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
23/07/2024
Highly accurate long-read sequencing data will be used at Novogene’s new lab in Munich, supporting customers across a network of leading research institutions MENLO PARK, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- PacBio [...]
Precision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly Advances
23/07/2024
Jayme Strauss and Mike Kaswan join as Chief Clinical and Commercial Officer and Chief Financial Officer, respectively, as the company progresses toward FDA clearance NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Precision [...]
Scilex Holding Company Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D.
23/07/2024
PALO ALTO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Electric is the Future: Chronus Health to Unveil its Electrical Sensing-Based Blood Testing Technology at ADLM 2024
23/07/2024
– New point-of-care rapid platform will drive accessibility and lower healthcare costs – FREMONT, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- Chronus Health , an innovator in point-of-care diagnostics, announced today [...]
INmune Bio Inc. Publishes Novel Biology on Natural Killer Cancer Immunotherapy INKmune™ in the Journal for ImmunoTherapy of Cancer
23/07/2024
Publication of detailed analysis on INKmune biology compared to cytokine stimulated cells demonstrates important anti-tumor memory like NK cell characteristics BOCA RATON, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- -- [...]
The Canadian Foundation for Women’s Health (CFWH) Launches Comprehensive Effort to Combat Maternal Morbidity and Mortality
23/07/2024
As Canada's maternal health suffers from ongoing deficiencies, the foundation urges immediate prevention and intervention with a multifaceted approach OTTAWA, July 23, 2024 (GLOBE NEWSWIRE) -- Despite Canada’s high- [...]
Announces Closing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
23/07/2024
July 23, 2024 Biodexa Pharmaceuticals PLC Announces Closing of $5.0 Million Registered Direct Offering and Concurrent Private Placement Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), an [...]
Milestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and Delaware
23/07/2024
ROSELAND, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that [...]
Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
23/07/2024
Patient dosing in the second cohort has commenced following the successful completion of the first cohort GLEN ALLEN, Va., July 23, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “ [...]
First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device
23/07/2024
DENVER, July 23, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) reports treatment of the first patient in a commercial setting with QUELIMMUNE™, its U.S. Food and Drug [...]
Cannara Biotech Reports Q3 2024 Financial Results
23/07/2024
Gross cannabis revenues before excise taxes increased to $26.2 million in Q3 2024 from $20.6 million in Q3 2023, a $5.6 million or 27.6%, increase. Total revenues, net of excise taxes, increased to $19.5 million in Q3 [...]
Cannara Biotech publie ses résultats financiers pour le troisième trimestre de 2024
23/07/2024
Les produits bruts du cannabis avant les taxes d’accise ont augmenté pour atteindre 26,2 millions de dollars au troisième trimestre 2024, contre 20,6 millions de dollars au troisième trimestre 2023, soit une [...]
Kane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve™ Antimicrobial Wound Gel
23/07/2024
Paves the Way for Kane’s revyve™ Antimicrobial Wound Gel Spray WINNIPEG, Manitoba, July 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that [...]
Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6, 2024
23/07/2024
GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second [...]
Vireo Growth Inc. to Release Second Quarter 2024 Results on August 6, 2024
23/07/2024
MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (formerly Goodness Growth Holdings, Inc.) ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), a cannabis company committed to providing safe access, [...]
BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024
23/07/2024
BURLINGTON, Mass. and JERUSALEM, July 23, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental [...]
Spectral AI Adds Three New Clinical Trial Sites To Expedite Emergency Department Patient Enrollment
23/07/2024
DALLAS, July 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
Spinogenix Announces Enrollment is Open for its Phase 2 Clinical Trial of SPG601 in Fragile X Syndrome
23/07/2024
U.S. FDA has granted Orphan Drug Designation to SPG601 for the Treatment of Fragile X Syndrome SPG601 is a novel small molecule that works by correcting specific synaptic dysfunctions in the brain to address core [...]
Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in France
23/07/2024
MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]

Pages